Ryanodex 250 MG vials
Ended Awarded Last action
- Contract number
- SPE2DR26FFL3P
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $1,601
Award facts
- Contract value 100% obligated
- $1,601.07 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $1,601.07 firm fixed-price delivery order to Amerisourcebergen Drug Corp (a subsidiary of Cencora, Inc.) on January 23, 2026, for 250 mg vials of Ryanodex, a rapid-sequence intubation agent used in emergency medical procedures. This is a competitively awarded, non-set-aside contract with performance through February 13, 2026, and will be fulfilled from the vendor's facility in Conshohocken, Pennsylvania. The award represents a task order under Amerisourcebergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs.
Amerisourcebergen Drug Corp is a major pharmaceutical distributor and established federal vendor that supplies a broad range of medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains to the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems. The company's extensive portfolio of competitively awarded delivery orders demonstrates its capability to efficiently fulfill government pharmaceutical procurement requirements at varying volumes, from low-value transactions to substantial orders. This delivery order exemplifies the company's continued role in supporting military medical readiness through the provision of critical pharmaceutical products.
Quick answers
Who was awarded contract SPE2DR26FFL3P?
SPE2DR26FFL3P was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 23, 2026.
How much is contract SPE2DR26FFL3P worth?
The government has obligated $1,601 on SPE2DR26FFL3P.
Is contract SPE2DR26FFL3P an order under another contract?
Yes. SPE2DR26FFL3P is a delivery order under SPE2DR25D1109, an indefinite delivery contract.
Was contract SPE2DR26FFL3P competed?
The extent of competition for SPE2DR26FFL3P was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award